共 42 条
[1]
Kumada H(2012)Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan J Hepatol 56 78-84
[2]
Toyota J(2012)Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C J Viral Hepat 19 e134-e142
[3]
Okanoue T(2013)Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines J Gastroenterol 48 1-12
[4]
Hayashi N(2012)Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening Hepatology 56 455-463
[5]
Okanoue T(2006)Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C World J Gastroenterol 12 3756-3759
[6]
Tsubouchi H(2009)Genome-wide association of Nature Genet 41 1105-1109
[7]
Chayama K(2010) with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Gastroenterology 139 1190-1197
[8]
Hayes CN(1998)ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy: a genome-wide study of Japanese HCV virus patients Hepatol Res 12 240-251
[9]
Ohishi W(2002)Randomized control trial of interferon-β injections at 12-h intervals as a therapy for chronic hepatitis C J Gastroenterol 37 40-46
[10]
Vujosevic S(2012)Possible mechanisms of elevation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients J Gastroenterol 47 606-607